Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jun 22, 2017 (9 years ago)

QUELICIN (Succinylcholine Chloride)

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

QUELICIN (Succinylcholine Chloride) Injection, USP 20 mg/mL in a) 5 mL vial (NDC 15082-814-67), b) 7mL vial (NDC 15082-814-79), c) 10mL vial (NDC 15082-814-61), Repackaged by Advanced Pharm, 9265 Kirby Dr., Houston, TX 77054 (877) 794-0404.

Affected NDCs 15082-0814-61 15082-0814-67 15082-0814-79

Compare with the code on your package — it is the most precise check available.

Drug: Succinylcholine

Recalling firm
Advanced Pharma Inc.
NDC code
15082-814-67
Origin
TX, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0953-2017 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Succinylcholine recalls

See all
Class II · Moderate risk

Succinylcholine Chloride Injection

Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation impurity.

Ongoing Impurity / degradation Zydus Pharmaceuticals (USA) Inc NDC 70710-1377-1 D-0623-2025

Other recalls by Advanced Pharma Inc.

All 2017 recalls